Allogene Therapeutics, Inc.
ALLO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $20K | −100% |
| Operating income | −$209M | −$273M | +23.4% |
| Net income | −$191M | −$258M | +25.9% |
Questions
- What was Allogene's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $20K a year earlier, per its 10-K filed Mar 2026.
- Was Allogene profitable in FY2025?
- No: net income was −$191M and operating income −$209M in FY2025.